The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?

Open Access

Alexander Arthur Wurm,

Affiliation Division of Hematology and Oncology, Leipzig University Hospital, Leipzig, Germany
⨯
Daniel G. Tenen,

Affiliations Cancer Science Institute, National University of Singapore, Singapore, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Gerhard Behre

* E-mail: Gerhard.Behre@medizin.uni-leipzig.de

Affiliation Division of Hematology and Oncology, Leipzig University Hospital, Leipzig, Germany
⨯

Reader Comments (0)

Acute myeloid leukemia
Is the Subject Area "Acute myeloid leukemia" applicable to this article?

Thanks for your feedback.
Leukemia
Is the Subject Area "Leukemia" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Carcinogenesis
Is the Subject Area "Carcinogenesis" applicable to this article?

Thanks for your feedback.
Cell differentiation
Is the Subject Area "Cell differentiation" applicable to this article?

Thanks for your feedback.
Hematopoiesis
Is the Subject Area "Hematopoiesis" applicable to this article?

Thanks for your feedback.
Oncogenes
Is the Subject Area "Oncogenes" applicable to this article?

Thanks for your feedback.